ES551821A0 - Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina. - Google Patents

Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina.

Info

Publication number
ES551821A0
ES551821A0 ES551821A ES551821A ES551821A0 ES 551821 A0 ES551821 A0 ES 551821A0 ES 551821 A ES551821 A ES 551821A ES 551821 A ES551821 A ES 551821A ES 551821 A0 ES551821 A0 ES 551821A0
Authority
ES
Spain
Prior art keywords
pepstatin
procedure
manufacture
peptide derivatives
analogue peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551821A
Other languages
English (en)
Other versions
ES8701783A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Sanofi SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8501982A external-priority patent/FR2577226B1/fr
Priority claimed from FR8501981A external-priority patent/FR2577225B1/fr
Application filed by Sanofi SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Sanofi SA
Publication of ES8701783A1 publication Critical patent/ES8701783A1/es
Publication of ES551821A0 publication Critical patent/ES551821A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES551821A 1985-02-12 1986-02-11 Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina. Expired ES8701783A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8501982A FR2577226B1 (fr) 1985-02-12 1985-02-12 Analogues de pepstatine inhibiteurs de la renine et des proteases acides
FR8501981A FR2577225B1 (fr) 1985-02-12 1985-02-12 Derives peptidiques inhibiteurs de la renine et des proteases acides

Publications (2)

Publication Number Publication Date
ES8701783A1 ES8701783A1 (es) 1987-01-01
ES551821A0 true ES551821A0 (es) 1987-01-01

Family

ID=26224369

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551820A Expired ES8701782A1 (es) 1985-02-12 1986-02-11 Un procedimiento para la fabricacion de derivados peptidicos inhibidores de la renina y de las proteasas acidas
ES551821A Expired ES8701783A1 (es) 1985-02-12 1986-02-11 Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES551820A Expired ES8701782A1 (es) 1985-02-12 1986-02-11 Un procedimiento para la fabricacion de derivados peptidicos inhibidores de la renina y de las proteasas acidas

Country Status (11)

Country Link
US (2) US4725580A (es)
EP (2) EP0192554B1 (es)
AT (2) ATE52518T1 (es)
AU (2) AU606572B2 (es)
CA (2) CA1286846C (es)
DE (2) DE3671021D1 (es)
DK (2) DK64086A (es)
ES (2) ES8701782A1 (es)
GR (2) GR860399B (es)
NZ (2) NZ215097A (es)
PT (2) PT81991B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585708B1 (fr) * 1985-07-31 1989-07-07 Sanofi Sa Derives aminoalcools peptidiques inhibiteurs de la resine et des proteases acides, leur procede de preparation et leur application en therapeutique
US4599198A (en) * 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis
DE3626130A1 (de) * 1986-08-01 1988-02-11 Merck Patent Gmbh Aminosaeurederivate
DE3640535A1 (de) * 1986-11-27 1988-06-01 Merck Patent Gmbh Peptide
EP0284510A3 (en) * 1987-03-24 1990-08-22 Asahi Breweries, Ltd. N-[N alpha-(1(S)-carboxy-3-cyclohexyl-propyl)-1-lysyl] N-cyclopentylglycine as antihypertensives
US4874745A (en) * 1987-10-01 1989-10-17 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
US4980283A (en) * 1987-10-01 1990-12-25 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
US5162527A (en) * 1987-10-26 1992-11-10 Warner-Lambert Company Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
KR890701619A (ko) * 1987-10-26 1989-12-22 크리스틴 에이.트러트웨인 레닌 억제제, 그의 제조 방법, 그 사용 방법 및 이들을 함유한 조성물
US5164388A (en) * 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
DK0383635T3 (da) * 1989-02-16 1995-11-20 Sankyo Co Peptider med renin-inhiberende virkning samt deres fremstilling og anvendelse
FR2646354B1 (fr) * 1989-04-27 1994-06-10 Sanofi Sa Utilisation de peptides inhibiteurs de proteases acides pour la preparation de medicaments utiles pour le traitement de maladies virales
US5238923A (en) * 1989-05-26 1993-08-24 Warner-Lambert Company Amino-substituted heterocycles as renin inhibitors
US5149692A (en) * 1989-12-21 1992-09-22 Warner-Lambert Company Bisalkoxyphosphinyl compounds as renin inhibitors
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
AT407043B (de) * 1998-01-23 2000-11-27 Martin Dr Kratzel Simplifizierte pepstatin-a-analoga, deren herstellung und verwendung
US7247704B2 (en) 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
US7929913B2 (en) 2002-12-16 2011-04-19 Intel Corporation Adaptive receiver architecture
AU2012216230B2 (en) 2011-02-08 2017-05-25 Merck Patent Gmbh Amino statin derivatives for the treatement of arthrosis
AU2013295391B2 (en) 2012-07-24 2018-03-08 Merck Patent Gmbh Hydroxystatin derivatives for treatment of arthrosis
WO2014127881A1 (de) 2013-02-25 2014-08-28 Merck Patent Gmbh 2-amino-3,4-dihydrc-chinazolin derivate und ihre verwendung als cathepsin d inhibitoren
AU2014304950B2 (en) 2013-08-06 2019-09-12 Merck Patent Gmbh Intraarticular application of pepstatin in the case of arthrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
EP0114993B1 (en) * 1982-12-27 1990-05-16 Merck & Co. Inc. Renin inhibitory tripeptides

Also Published As

Publication number Publication date
ATE52518T1 (de) 1990-05-15
DK64186A (da) 1986-08-13
PT81990B (pt) 1988-03-03
CA1286847C (en) 1991-07-23
AU606572B2 (en) 1991-02-14
DE3683170D1 (de) 1992-02-13
GR860398B (en) 1986-06-12
ES551820A0 (es) 1986-12-16
PT81991B (pt) 1988-03-03
PT81991A (fr) 1986-03-01
ES8701782A1 (es) 1986-12-16
PT81990A (fr) 1986-03-01
NZ215096A (en) 1989-10-27
EP0192554A1 (fr) 1986-08-27
ES8701783A1 (es) 1987-01-01
DK64186D0 (da) 1986-02-10
CA1286846C (en) 1991-07-23
DK64086D0 (da) 1986-02-10
EP0193445B1 (fr) 1990-05-09
ATE71111T1 (de) 1992-01-15
EP0192554B1 (fr) 1992-01-02
US4725580A (en) 1988-02-16
AU5327386A (en) 1986-08-21
GR860399B (en) 1986-06-12
DK64086A (da) 1986-08-13
DE3671021D1 (de) 1990-06-13
AU5327286A (en) 1986-08-14
AU606312B2 (en) 1991-02-07
US4746648A (en) 1988-05-24
NZ215097A (en) 1990-04-26
EP0193445A1 (fr) 1986-09-03

Similar Documents

Publication Publication Date Title
ES551821A0 (es) Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina.
DE3874798T2 (de) Therapeutisches proteinagens in form von aerosol.
ES2103305T3 (es) Produccion de inhibidor de interleuquina-1 humana recombinada.
NO163857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
ES548534A0 (es) Procedimiento para la fabricacion de derivados de pirazol tienil condensados
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
IT1184883B (it) Procedimento perfezionato per la produzione di proteine particolarmente anticorpi con l impiego di mezzi ipertonici e mezzo ipertonico per l attuazione di tale procedimento
DE3575872D1 (de) Thioether-sorbentmittel fuer die trennung von proteinen und dergleichen.
IT8222834A0 (it) Isomeri di amminoacidi eprocedimento per la loro produzione.
ES549065A0 (es) Procedimiento para la preparacion y purificacion de peptidos
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO853737L (no) Fremgangsm¨te ved fremstilling av furan-3-karboksylsyrer o g derivater derav.
NO861772L (no) Fremgangsmaate for fremstilling av proteinhydrolysat.
ES552407A0 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
ES557727A0 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
ES543138A0 (es) Procedimiento para la eliminacion de arsenico de acidos sul-furicos de desecho
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
IT1223080B (it) Procedimento per la fabbricazione di corpi tubolari leggeri e corpo tubolare ottenuto tramite detto procedimento
NO863225D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzodioxepaner.
NO170422C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptider
ES552441A0 (es) Procedimiento industrial para la fabricacion de suelas para calzados
KR880018999U (ko) 신발의 공기밸브
NO164532C (no) Analogifremgangsmaate for fremstilling av acetyldikarnitindiklorid.
ES550553A0 (es) Procedimiento para la obtencion de n-(diamino-fosfinil)halo-benzamidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303